{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:02:53Z","timestamp":1780084973045,"version":"3.54.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010012","name":"National Aerospace Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Shaanxi Province Key Research and Development Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijbiomac.2023.125009","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:14:58Z","timestamp":1685067298000},"page":"125009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis, cytotoxicity, and biomacromolecule binding: Three isomers of nitrosylruthenium complexes with bidentate bioactive molecules as co-ligands"],"prefix":"10.1016","volume":"243","author":[{"given":"Hehe","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.125009_bb0005","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2174\/156802611794785226","article-title":"Transition metal based anticancer drugs","volume":"11","author":"Garbutcheon-Singh","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal complexes in cancer therapy - an update from drug design perspective","volume":"11","author":"Ndagi","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0025","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1039\/C8MT00024G","article-title":"Metallomic study on the metabolism of RAPTA-C and cisplatin in cell culture medium and its impact on cell accumulation","volume":"10","author":"Holtkamp","year":"2018","journal-title":"Metallomics"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0035","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1021\/acs.inorgchem.9b00708","article-title":"Targeting energy metabolism by a platinum(IV) prodrug as an alternative pathway for cancer suppression","volume":"58","author":"Jin","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0040","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1039\/c2cs15299a","article-title":"Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics","volume":"41","author":"Gill","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0045","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1021\/ja303091q","article-title":"Mesoscale DNA structural changes on binding and photoreaction with Ru[(TAP)2PHEHAT]2+","volume":"134","author":"Vanderlinden","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0050","doi-asserted-by":"crossref","first-page":"11274","DOI":"10.1021\/ja4045604","article-title":"Cellular toxicity induced by the photorelease of a caged bioactive molecule: design of a potential dual-action Ru(II) complex","volume":"135","author":"Sgambellone","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0055","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1021\/acs.accounts.7b00180","article-title":"Critical overview of the use of Ru(II) polypyridyl complexes as photosensitizers in one-photon and two-photon photodynamic therapy","volume":"50","author":"Heinemann","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0060","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/nbt873","article-title":"Electrochemical DNA sensors","volume":"21","author":"Drummond","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0065","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nchem.1397","article-title":"Crystal structures of \u039b-[Ru(phen)dppz]2+ with oligonucleotides containing TA\/TA and AT\/AT steps show two intercalation modes","volume":"4","author":"Niyazi","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0070","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1093\/nar\/gkw753","article-title":"Delta chirality ruthenium \u2018light-switch\u2019 complexes can bind in the minor groove of DNA with five different binding modes","volume":"44","author":"Hall","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0075","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acs.jpcb.2c02104","article-title":"Comparative studies on DNA-binding mechanisms between enantiomers of a polypyridyl ruthenium(II) complex","volume":"126","author":"Nie","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0080","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1039\/C7CS00680B","article-title":"The development of ruthenium(II) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications","volume":"24","author":"Poynton","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0085","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1021\/acs.jmedchem.0c00431","article-title":"Ruthenium(II) complex containing a redox-active semiquinonate ligand as a potential chemotherapeutic agent: from synthesis to in vivo studies","volume":"63","author":"Notaro","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0090","doi-asserted-by":"crossref","first-page":"16631","DOI":"10.1002\/anie.202006089","article-title":"Necroptosis induced by ruthenium(II) complexes as dual catalytic inhibitors of topoisomerase I\/II","volume":"59","author":"Xiong","year":"2020","journal-title":"Angew. Chem. Int. Edit."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003294","article-title":"Incorporation of Ru(II) polypyridyl complexes into nanomaterials for cancer therapy and diagnosis","volume":"32","author":"Soliman","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0100","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1038\/s41467-022-30721-w","article-title":"A supramolecular photosensitizer derived from an Arene-Ru(II) complex self-assembly for NIR activated photodynamic and photothermal therapy","volume":"13","author":"Xu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113262","article-title":"Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies","volume":"216","author":"Teixeira","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2019.07.008","article-title":"Chemistry and reactivity of ruthenium(II) complexes: DNA\/protein binding mode and anticancer activity are related to the complex structure","volume":"398","author":"Rilak Simovic","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0115","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1021\/acs.inorgchem.0c01433","article-title":"Differences in stability, cytotoxicity, and mechanism of action of Ru(II) and Pt(II) complexes of a bidentate N,O donor ligand","volume":"59","author":"Maji","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0120","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1039\/C9CC04098F","article-title":"Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy","volume":"55","author":"Liu","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0125","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1039\/C9DT02078K","article-title":"Ruthenium-arene complexes bearing naphthyl-substituted 1,3-dioxoindan-2-carboxamides ligands for G-quadruplex DNA recognition","volume":"48","author":"Hager","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0130","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.3390\/molecules25204699","article-title":"Antitumor activity of ruthenium(II) terpyridine complexes towards colon cancer cells in vitro and in vivo","volume":"25","author":"Savic","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0135","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.20.1.015004","article-title":"Photo-controlled NO release from two nitrosylruthenium isomer complexes and their potential biomedical applications","volume":"20","author":"Liu","year":"2015","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0145","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.chembiol.2011.09.009","article-title":"Generation, translocation, and action of nitric oxide in living systems","volume":"18","author":"Tennyson","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0150","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.ccr.2007.11.011","article-title":"Photoactive ruthenium nitrosyls: effects of light and potential application as NO donors","volume":"252","author":"Rose","year":"2008","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0155","doi-asserted-by":"crossref","first-page":"18145","DOI":"10.1021\/ja408516w","article-title":"Nitric oxide releasing materials triggered by near-infrared excitation through tissue filters","volume":"135","author":"Burks","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0160","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.cell.2019.01.037","article-title":"Regulation of microRNA machinery and development by interspecies S-nitrosylation","volume":"176","author":"Seth","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0165","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2016.05.007","article-title":"8-Hydroxyquinolines in medicinal chemistry: a structural perspective","volume":"120","author":"Oliveri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0170","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-06-3546","article-title":"Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0175","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1039\/c1dt10870k","article-title":"Interaction of Zn(II) with quinolone drugs: structure and biological evaluation","volume":"40","author":"Tarushi","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0180","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1039\/C6MD00073H","article-title":"Cobalt(ii) 8-hydroxyquinoline complexes: structure, cytotoxicity and action mechanism","volume":"7","author":"Zhang","year":"2016","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0185","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1021\/acs.inorgchem.6b00028","article-title":"DNA photocleavage by non-innocent ligand-based Ru(II) complexes","volume":"55","author":"Zhang","year":"2016","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13643-019-1231-1","article-title":"The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol","volume":"8","author":"Millard","year":"2019","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02617-20","article-title":"Overcoming the challenges of pyrazinamide susceptibility testing in clinical mycobacterium tuberculosis isolates","volume":"65","author":"Mok","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0200","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41467-021-24127-3","article-title":"Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide","volume":"12","author":"Santucci","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0205","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/acsinfecdis.2c00133","article-title":"Structural and mechanistic insights into mycobacterium abscessus aspartate decarboxylase panD and a pyrazinoic acid-derived inhibitor","volume":"8","author":"Saw","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0210","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium complexes as anticancer agents: a brief history and perspectives","volume":"14","author":"Lee","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0215","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1021\/acs.inorgchem.1c01441","article-title":"Insights into the protein ruthenation mechanism by antimetastatic metallodrugs: high-resolution X-ray structures of the adduct formed between Hen Egg-White Lysozyme and NAMI-A at various time points","volume":"60","author":"Chiniadis","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0220","article-title":"Chiral RuII-PtII complexes inducing telomere dysfunction against cisplatin-resistant cancer cells","volume":"61","author":"Xiong","year":"2022","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/00958972.2023.2192331","article-title":"Spectroscopy, docking and molecular dynamics studies on the interaction between cis and trans palladium-alanine complexes with calf-thymus DNA and antitumor activities","volume":"76","author":"Izadyar","year":"2023","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11164-018-3608-5","article-title":"Characterization of the structural changes of human serum albumin upon interaction with single-walled and multi-walled carbon nanotubes: spectroscopic and molecular modeling approaches","volume":"45","author":"Hosseinzadeh","year":"2019","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0235","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijbiomac.2020.02.064","article-title":"Catalytic activity and structural changes of catalase in the presence of Levothyroxine and Isoxsuprine hydrochloride","volume":"152","author":"Shahraki","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/bio.4506","article-title":"Probing the combination of erlotinib hydrochloride, an anticancer drug, and human serum albumin. Spectroscopic, molecular docking and molecular dynamic analysis","author":"Shahraki","year":"2023","journal-title":"Luminescence"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.120826","article-title":"Exploring the HSA\/DNA\/lung cancer cells binding behavior of p-Synephrine, a naturally occurring phenyl ethanol amine with anti-adipogenic activity: multi spectroscopic, molecular dynamic and cellular approaches","volume":"368","author":"Taheri","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0250","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1080\/07391102.2016.1264892","article-title":"Multi-spectroscopic and molecular modeling studies of interaction between two different angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate and human serum albumin","volume":"35","author":"Darban","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0255","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1021\/acs.jmedchem.6b00600","article-title":"X-ray structure analysis of indazolium trans-[Tetrachlorobis(1H -indazole) ruthenate(III)] (KP1019) bound to human serum albumin reveals two ruthenium binding sites and provides insights into the drug binding mechanism","volume":"59","author":"Bijelic","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0260","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.2174\/0929867326666190320105316","article-title":"Structural basis of drug recognition by human serum albumin","volume":"27","author":"Leboffe","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0265","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/biom9060218","article-title":"Albumin nanovectors in cancer therapy and imaging","volume":"9","author":"Parodi","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.08.015","article-title":"Controlled loading of albumin-drug conjugates ex vivo for enhanced drug delivery and antitumor efficacy","volume":"328","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.poly.2017.08.036","article-title":"Photo-induced cytotoxicity, photo-controlled nitric oxide release and DNA\/human serum albumin binding of three water-soluble nitrosylruthenium complexes","volume":"137","author":"Xu","year":"2017","journal-title":"Polyhedron"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0280","unstructured":"G.M. Sheldrick, SADABS 2.05, University of G\u00f6ttingen, Germany."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0285","series-title":"SHELX97, Program for Crystal Structure Solution","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. Sect. A: Found. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0295","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118468","article-title":"Fluorescence properties of phycocyanin and phycocyanin-human serum albumin complex","volume":"239","author":"Seyedi","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0305","doi-asserted-by":"crossref","first-page":"13387","DOI":"10.1039\/D1DT02180J","article-title":"Synthesis, crystal structures, anticancer activities and molecular docking studies of novel thiazolidinone cu(II) and Fe(III) complexes targeting lysosomes: special emphasis on their binding to DNA\/BSA","volume":"50","author":"Shao","year":"2003","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejmech.2014.08.071","article-title":"Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin","volume":"86","author":"Zhang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0315","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1021\/acs.inorgchem.1c00762","article-title":"Structural and photodynamic studies on nitrosylruthenium-complexed serum albumin as a delivery system for controlled NO release","volume":"60","author":"Xie","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.888693","article-title":"Spectroscopy, structure, biomacromolecular interactions, and antiproliferation activity of a Fe(II) complex with DPA-Bpy as pentadentate ligand","volume":"10","author":"Bai","year":"2022","journal-title":"Front Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0325","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1107\/S0907444906019949","article-title":"HKL-3000: the integration of data reduction and structure solution - from diffraction images to an initial model in minutes","volume":"62","author":"Minor","year":"2006","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0330","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0335","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0340","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0350","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0355","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1021\/ic702160w","article-title":"Formation, reactivity, and photorelease of metal bound nitrosyl in [Ru(trpy)(L)(NO)](n+) (trpy = 2,2\u2032:6\u2032,2\u2033-terpyridine, L = 2-phenylimidazo[4,5-f]1,10-phenanthroline)","volume":"47","author":"Maji","year":"2008","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0360","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ejic.201101026","article-title":"Ruthenium(III) cyclometalates obtained by site-specific orthometallation and their reactivity with nitric oxide: photoinduced release and estimation of NO liberated from the ruthenium nitrosyl complexes","volume":"2012","author":"Ghosh","year":"2012","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0365","doi-asserted-by":"crossref","first-page":"10772","DOI":"10.1039\/D0DT01788D","article-title":"Near-IR light-induced photorelease of nitric oxide (NO) on ruthenium nitrosyl complexes: formation, reactivity, and biological effects","volume":"49","author":"Giri","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0370","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1021\/acs.inorgchem.1c03011","article-title":"The ruthenium nitrosyl moiety in clusters: trinuclear linear \u03bc-Hydroxido magnesium(II)-diruthenium(II), \u03bc3-oxido trinuclear diiron(III)-ruthenium(II), and tetranuclear \u03bc4-oxido trigallium(III)-ruthenium(II) complexes","volume":"61","author":"Stepanenko","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0375","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1039\/b905798f","article-title":"A categorization of metal anticancer compounds based on their mode of action","volume":"37","author":"Gianferrara","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0380","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/nar\/gkm032","article-title":"Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin","volume":"35","author":"Chvalova","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0385","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0390","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1021\/acs.inorgchem.8b00053","article-title":"A cancer cell-selective and low-toxic bifunctional heterodinuclear Pt(IV)-Ru(II) anticancer prodrug","volume":"57","author":"Ma","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0395","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ejmech.2017.11.044","article-title":"Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: a synthetic, structural and detailed mechanistic anticancer investigation","volume":"143","author":"Rahman","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0400","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/acs.inorgchem.1c03770","article-title":"Dissociation of bipyridine and coordination with nitrosyl: cyclometalated ruthenium nitrosyl complex","volume":"61","author":"Wu","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0410","doi-asserted-by":"crossref","first-page":"mfac043","DOI":"10.1093\/mtomcs\/mfac043","article-title":"The aqueous stability and interactions of organoruthenium compounds with serum proteins, cell culture medium, and human serum","volume":"14","author":"Riisom","year":"2022","journal-title":"Metallomics"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0415","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.7150\/thno.19365","article-title":"Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery","volume":"7","author":"An","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0420","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/ja908878n","article-title":"Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146","volume":"132","author":"Yamaguchi","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0425","first-page":"5356","article-title":"Structural studies of several clinically important oncology drugs in complex with human serum albumin","volume":"2013","author":"Wang","year":"1830","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0430","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/acs.molpharmaceut.8b00045","article-title":"Developing an anticancer copper(II) multitarget pro-drug based on the His146 residue in the IB subdomain of modified human serum albumin","volume":"15","author":"Wang","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0435","doi-asserted-by":"crossref","first-page":"14045","DOI":"10.1021\/acs.jmedchem.0c01578","article-title":"Structural basis for the binding mechanism of human serum albumin complexed with cyclic peptide dalbavancin","volume":"63","author":"Ito","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0440","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.aca.2017.10.026","article-title":"Inner filter effect-based fluorescent sensing systems: a review","volume":"999","author":"Chen","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0445","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/07391102.2020.1724568","article-title":"Oil-in-water nanoemulsions comprising Berberine in olive oil: biological activities, binding mechanisms to human serum albumin or holo-transferrin and QMMD simulations","volume":"39","author":"Sharifi-Rad","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2023.125009_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.119042","article-title":"Novel perspective into the interaction behavior study of the cyanidin with human serum albumin-holo transferrin complex: spectroscopic, calorimetric and molecular modeling approaches","volume":"356","author":"Khashkhashi-Moghadam","year":"2022","journal-title":"J. Mol. Liq."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023019037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023019037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:21:26Z","timestamp":1758882086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023019037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":89,"alternative-id":["S0141813023019037"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125009","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, cytotoxicity, and biomacromolecule binding: Three isomers of nitrosylruthenium complexes with bidentate bioactive molecules as co-ligands","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"125009"}}